These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19995151)

  • 41. The need for tissue selective menopausal agents.
    Eden J
    Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():22-7. PubMed ID: 16112952
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group.
    Kenemans P; Speroff L;
    Maturitas; 2005 May; 51(1):21-8. PubMed ID: 15883105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 3beta-OH-tibolone acutely dilates rat muscle arterioles similar to 3alpha-OH-tibolone.
    Korstjens IJ; van der Mooren MJ; Kloosterboer HJ; Sipkema P
    Menopause; 2008; 15(2):386-7. PubMed ID: 18000470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of tibolone on turnover of cholesterol to bile acids in ovariectomized rats.
    Czerny B; Teister M; Juzyszyn Z; Mysliwiec Z; Pawlik A
    Menopause; 2005; 12(5):609-12. PubMed ID: 16145315
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endometrial cancer--surprising reports.
    Speroff L
    Maturitas; 2005 Aug; 51(4):329-33. PubMed ID: 16039404
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of tibolone on selectins in postmenopausal women.
    Sator K; Sator MO; Sator PG; Egarter C; Huber JC
    Maturitas; 2006 Jan; 53(2):166-70. PubMed ID: 15894441
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Relation between hormonal therapy and tibolone with SERMs in postmenopausal women's myomes growth].
    Carranza Lira S
    Ginecol Obstet Mex; 2008 Oct; 76(10):610-4. PubMed ID: 19062511
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Caring for the breast cancer survivor.
    Abdel-Razeq H
    Am J Med; 2011 Feb; 124(2):e11; author reply e13. PubMed ID: 21295181
    [No Abstract]   [Full Text] [Related]  

  • 49. Prevention of breast cancer using selective oestrogen receptor modulators (SERMs).
    Powles TJ
    Breast Cancer Res; 2006; 8(5):111. PubMed ID: 17049068
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
    Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
    Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
    Odmark IS; Carlström K; Jonsson B; Jonasson AF
    Maturitas; 2006 Jan; 53(1):89-96. PubMed ID: 15964160
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Significant differential effects of hormone therapy or tibolone on markers of cardiovascular disease in postmenopausal women: a randomized, double-blind, placebo-controlled, crossover study.
    Koh KK; Ahn JY; Jin DK; Yoon BK; Kim HS; Kim DS; Kang WC; Han SH; Choi IS; Shin EK
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1889-94. PubMed ID: 12933531
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cognitive function variations in postmenopausal women treated with continuous, combined HRT or tibolone. A comparison.
    Pan HA; Wang ST; Pai MC; Chen CH; Wu MH; Huang KE
    J Reprod Med; 2003 May; 48(5):375-80. PubMed ID: 12815913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The safety of tibolone in epithelial ovarian cancer patients.
    Lee KB; Lee JM; Yoon JH; Park CY
    Maturitas; 2006 Sep; 55(2):156-61. PubMed ID: 16563669
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of tibolone versus 17beta-estradiol on climacteric symptoms in women with surgical menopause: a randomized, cross-over study.
    Somunkiran A; Erel CT; Demirci F; Senturk ML
    Maturitas; 2007 Jan; 56(1):61-8. PubMed ID: 16831525
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability.
    Hammar ML; van de Weijer P; Franke HR; Pornel B; von Mauw EM; Nijland EA;
    BJOG; 2007 Dec; 114(12):1522-9. PubMed ID: 17995496
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tibolone (Livial) enhances warfarin-induced anticoagulation in postmenopausal women.
    Elbers J; Hageluken C; Wadham A
    Maturitas; 2007 Jan; 56(1):94-100. PubMed ID: 16887301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate.
    Uygur D; Yeşildaglar N; Erkaya S
    Gynecol Endocrinol; 2005 Apr; 20(4):209-12. PubMed ID: 16019363
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tibolone exerts its protective effect on trabecular bone loss through the estrogen receptor.
    Ederveen AG; Kloosterboer HJ
    J Bone Miner Res; 2001 Sep; 16(9):1651-7. PubMed ID: 11547834
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tibolone-induced acute hepatitis: Well-known drug, little-known complication.
    Macedo G; Silva M; Vilas-Boas F; Lopes S; Peixoto A; Carneiro F
    Gastroenterol Hepatol; 2017 Apr; 40(4):298-300. PubMed ID: 27093896
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.